Profilo
Timothy G.
Whitten is currently President & Chief Executive Officer at Insmed Ltd. since 2009.
Former positions include President, Chief Executive Officer & Director at Insmed, Inc. from 2010 to 2012; Chief Executive Officer & Director at Taiho Oncology, Inc. in 2026; President & Chief Executive Officer at Transave, Inc.; Vice President-Global Marketing at Bristol Myers Squibb Co.; and Senior VP-Commercial Operations & Development at Pharmacyclics LLC.
Education includes an MBA from the University of Virginia and an undergraduate degree from West Virginia University.
Posizioni attive di Timothy G. Whitten
| Società | Posizione | Inizio |
|---|---|---|
Insmed Ltd.
Insmed Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for the treatment of lung diseases | Amministratore Delegato | 10/06/2009 |
Precedenti posizioni note di Timothy G. Whitten
| Società | Posizione | Fine |
|---|---|---|
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Amministratore Delegato | 28/01/2026 |
| INSMED INCORPORATED | Presidente | 10/09/2012 |
| BRISTOL-MYERS SQUIBB COMPANY | Vendite & Marketing | - |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Presidente | - |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Formazione di Timothy G. Whitten
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Virginia University
West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Health Technology |
Insmed Ltd.
Insmed Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for the treatment of lung diseases | Health Technology |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Health Technology |
















